Comparison of PPD and IGST Sensitivity in Latent Tuberculosis Assessment (Cross-sectional Study)
Open Access
- 1 January 2025
- journal article
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
- Vol. 15 (3) , 249-256
Abstract
Objective: Purified Protein Derivative (PPD) and Interferon Gamma Release Assay (IGRA) were performed on patients with ankylosing spondylitis and rheumatoid arthritis who were planned to initiate immunosuppressive treatment. The aim was to determine which test would be more appropriate for diagnosing latent tuberculosis (TB) and to evaluate the sensitivity and specificity of PPD and IGRA tests in latent TB diagnosis. Materials and Methods: Forty-seven patients with rheumatoid arthritis and 27 patients with ankylosing spondylitis were included in the study. All patients underwent both PPD and QuantiFERON-TB Gold Plus testing. Latent TB was defined as close contact with active tuberculosis infection and/or presence of suspicious fibrotic/calcified lesions on chest radiography without active tuberculosis infection. Results: The QuantiFERON-TB Gold Plus test demonstrated a specificity of 96.6% and sensitivity of 73.3%, while the tuberculin skin test (TST) showed a specificity of 25.4% and sensitivity of 93.3%. A significant correlation was found between the QuantiFERON-TB Gold Plus test and latent tuberculosis criteria (p<0.001, r=0.562), whereas no statistically significant correlation existed between TST and latent tuberculosis criteria (p=0.309, r=0.120). Conclusion: The IGRA test demonstrated higher specificity and sensitivity compared to TST. Given the lower specificity of TST observed in our study compared to other studies, the IGRA test may be recommended for patients planned to receive prophylactic treatment.Keywords
This publication has 20 references indexed in Scilit:
- Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasisJournal of Infection, 2014
- Screening of tuberculosis before biologicsMedecine Et Maladies Infectieuses, 2012
- Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in KoreaClinical Rheumatology, 2011
- Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-AnalysisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatmentJoint Bone Spine, 2010
- Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin testBritish Journal of Dermatology, 2009
- A new evolutionary scenario for the Mycobacterium tuberculosis complexProceedings of the National Academy of Sciences, 2002
- Cell-Mediated Immune Response to Tuberculosis Antigens: Comparison of Skin Testing and Measurement of In Vitro Gamma Interferon Production in Whole-Blood CultureClinical and Diagnostic Laboratory Immunology, 2001
- Comparative Evaluation of Low-Molecular-Mass Proteins fromMycobacterium tuberculosisIdentifies Members of the ESAT-6 Family as Immunodominant T-Cell AntigensInfection and Immunity, 2000
- The Tuberculin Skin TestClinical Infectious Diseases, 1993